A new candidate human inactivated rotavirus vaccine strain (ZTR-68) was isolated from children in China and demonstrated immunogenicity, providing a basis for future vaccine development.
ZTR-68 immunogenicity supports rotavirus vaccine candidate pursuit; leaves open human efficacy and safety trials.
AIM: gene in hospitalized children in Yunnan, China. METHODS: gene was performed. Rotavirus isolation was performed, and characterized by plaque, minimum essential medium, and all genes sequence analysis. Quantification of antibodies for inactivated vaccine prepared with ZTR-68 was examined by enzyme-linked immunosorbent assay and microneutralization assay. RESULTS: genotypes of strain ZTR-68 were similar to Wa-like strains.CONCLUSIONSA high prevalence of the G1, G2, and G3 genotypes was detected from 2010 to 2012. However, a dominant prevalence of the G9 genotype was identified as the cause of gastroenteritis in children in Yunnan, China, in 2013. A candidate human inactivated rotavirus vaccine strain, designated ZTR-68 was isolated, characterized, and showed immunogenicity. Our data will be useful for the future formulation and development of a vaccine in China.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2018) studied Gastroenteritis. Rotavirus strain ZTR-68 isolation and characterization was evaluated on Rotavirus genotype prevalence and vaccine strain immunogenicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from World Journal of Clinical Cases